Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement

L Puente-Maestu, P Palange… - European …, 2016 - publications.ersnet.org
This document reviews 1) the measurement properties of commonly used exercise tests in
patients with chronic respiratory diseases and 2) published studies on their utilty and/or …

Recommendations on the use of exercise testing in clinical practice

P Palange, SA Ward, KH Carlsen… - European …, 2006 - publications.ersnet.org
Evidence-based recommendations on the clinical use of cardiopulmonary exercise testing
(CPET) in lung and heart disease are presented, with reference to the assessment of …

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

DP Tashkin, B Celli, S Senn, D Burkhart… - … England Journal of …, 2008 - Mass Medical Soc
Background Previous studies showing that tiotropium improves multiple end points in
patients with chronic obstructive pulmonary disease (COPD) led us to examine the long-term …

Outcomes for COPD pharmacological trials: from lung function to biomarkers

M Cazzola, W MacNee, FJ Martinez… - European …, 2008 - publications.ersnet.org
The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …

Pulmonary function testing in COPD: looking beyond the curtain of FEV1

S Kakavas, OS Kotsiou, F Perlikos, M Mermiri… - NPJ primary care …, 2021 - nature.com
Chronic obstructive pulmonary disease (COPD) management remains challenging due to
the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the …

[HTML][HTML] Physical inactivity in patients with COPD, a controlled multi-center pilot-study

T Troosters, F Sciurba, S Battaglia, D Langer… - Respiratory …, 2010 - Elsevier
BACKGROUND: Physical activity (PA) has been reported to be reduced in severe chronic
obstructive pulmonary disease (COPD). Studies in moderate COPD are currently scarce …

Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease

DE O'Donnell - Proceedings of the American Thoracic Society, 2006 - atsjournals.org
Expiratory flow limitation is the pathophysiologic hallmark of chronic obstructive pulmonary
disease (COPD), but dyspnea (breathlessness) is its most prominent and distressing …

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease–2007 update

DE O'donnell, S Aaron, J Bourbeau… - Canadian …, 2007 - Wiley Online Library
Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that
is both preventable and treatable. Our understanding of the pathophysiology of this complex …

Pathogenesis of hyperinflation in chronic obstructive pulmonary disease

P Gagnon, JA Guenette, D Langer… - … journal of chronic …, 2014 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable lung disease
characterized by airflow limitation that is not fully reversible. In a significant proportion of …

Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable

DE O'Donnell, RB Banzett… - Proceedings of the …, 2007 - atsjournals.org
Effective management of dyspnea in chronic obstructive pulmonary disease (COPD)
requires a clearer understanding of its underlying mechanisms. This roundtable reviews …